BrainStorm Shareholder Seeks Access to Board’s FDA Snub Records

A BrainStorm Cell Therapeutics Inc. stockholder requested a Delaware court order the biopharmaceutical company turn over board minutes and other documents tied to a stem-cell treatment that failed to get regulatory approval.

The shareholder wants access to these books and records to investigate alleged wrongdoing, mismanagement, and the ability of directors and officers to impartially consider legal action in the company’s interest, said her complaint filed in Delaware Chancery Court Dec. 31.

Shari Roth’s demand comes several months after a US District Court for the Southern District of New York judge partially allowed different BrainStorm investors’ proposed class allegations to ...